These protective effects of omentin in both obesity and cardiovascular disease seem to be based on disease-specific effects, for example, an insulin sensitizing effect in obesity [36] and modulation of NO synthase function in the coronary endothelium [37]. The gene discussed is ITLN1; the disease is obesity due to melanocortin 4 receptor deficiency.